glucose, (beta-d)-isomer has been researched along with Cardiomyopathy, Dilated in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bisping, E; Gasser, R; Grimm, M; Haas, T; Huber, MS; Pieske, B; Rainer, PP; Roessl, U; von Lewinski, D; Wasler, A; Wilhelm, B | 1 |
1 other study(ies) available for glucose, (beta-d)-isomer and Cardiomyopathy, Dilated
Article | Year |
---|---|
Functional effects of glucose transporters in human ventricular myocardium.
Topics: Aged; Carbonates; Cardiomyopathy, Dilated; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Glucose Transporter Type 1; Glucose Transporter Type 4; Glucosides; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Inhibitory Concentration 50; Insulin; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Phosphoinositide-3 Kinase Inhibitors; RNA, Messenger; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2010 |